Related Experiment Video

Updated: Mar 6, 2026

Author Spotlight: Advancing Antibiotic Resistance Research Using an Efflux-Deficient Bacterial Strain and a Single-Copy Gene Expression System
05:06

Author Spotlight: Advancing Antibiotic Resistance Research Using an Efflux-Deficient Bacterial Strain and a Single-Copy Gene Expression System

Published on: January 5, 2024

1.1K

Characterization of Transformants Obtained From NDM-1-Producing Enterobacteriaceae in Brazil

Franciéli P Rozales1, Cibele M Magagnin1, Juliana C Campos2

  • 11Laboratório de Pesquisa em Resistência Bacteriana (LABRESIS),Centro de Pesquisa Experimental,Hospital de Clínicas de Porto Alegre (HCPA),Porto Alegre,Brazil.

Infection Control and Hospital Epidemiology
|March 8, 2017
PubMed
Abstract

No abstract available in PubMed .

More Related Videos

Characterization of a Pathogenic Escherichia coli Strain Derived from Oreochromis spp. Farms Using Whole-Genome Sequencing
09:44

Characterization of a Pathogenic Escherichia coli Strain Derived from Oreochromis spp. Farms Using Whole-Genome Sequencing

Published on: December 23, 2022

3.0K
Generation of Enterobacter sp. YSU Auxotrophs Using Transposon Mutagenesis
13:31

Generation of Enterobacter sp. YSU Auxotrophs Using Transposon Mutagenesis

Published on: October 31, 2014

14.5K

Related Experiment Videos

Last Updated: Mar 6, 2026

Author Spotlight: Advancing Antibiotic Resistance Research Using an Efflux-Deficient Bacterial Strain and a Single-Copy Gene Expression System
05:06

Author Spotlight: Advancing Antibiotic Resistance Research Using an Efflux-Deficient Bacterial Strain and a Single-Copy Gene Expression System

Published on: January 5, 2024

1.1K
Characterization of a Pathogenic Escherichia coli Strain Derived from Oreochromis spp. Farms Using Whole-Genome Sequencing
09:44

Characterization of a Pathogenic Escherichia coli Strain Derived from Oreochromis spp. Farms Using Whole-Genome Sequencing

Published on: December 23, 2022

3.0K
Generation of Enterobacter sp. YSU Auxotrophs Using Transposon Mutagenesis
13:31

Generation of Enterobacter sp. YSU Auxotrophs Using Transposon Mutagenesis

Published on: October 31, 2014

14.5K

Related Concept Videos

Bacterial Transformation01:33

Bacterial Transformation

61.8K
In 1928, bacteriologist Frederick Griffith worked on a vaccine for pneumonia, which is caused by Streptococcus pneumoniae bacteria. Griffith studied two pneumonia strains in mice: one pathogenic and one non-pathogenic. Only the pathogenic strain killed host mice.
Griffith made an unexpected discovery when he killed the pathogenic strain and mixed its remains with the live, non-pathogenic strain. Not only did the mixture kill host mice, but it also contained living pathogenic bacteria that...
61.8K
Transformation01:26

Transformation

1.2K
Microbial communities are dynamic environments where cell lysis releases free DNA into the surroundings. Other cells can take up this extracellular DNA through a process known as transformation.When a cell incorporates this foreign DNA into its genome, resulting in genetic modification, the process is known as transformation. Cells capable of this process are termed competent. Competence can be natural, as observed in certain bacteria and archaea, or artificially induced in the...
1.2K

Articles linked to this work by shared authors, journal, and citation graph.

Population pharmacokinetics of polymyxin B: an individual participant data meta-analysis.

Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases·2026

Global Survey on the Management of Multidrug-resistant Gram-negative Bacilli: Divergence of Practice Between High-Income Countries and the Rest of the World.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2026

Molecular Epidemiology of Methicillin-Resistant Staphylococcus aureus Causing Healthcare-Associated Bloodstream Infections in Brazil: Results from A Prospective Countrywide Multicenter Study.

Infectious diseases and therapy·2025

Population Pharmacokinetic/Toxicodynamic Model for Polymyxin B in Critically Ill Patients to Identify the Risk of Nephrotoxicity.

Clinical pharmacology and therapeutics·2025

World Health Organization priority antimicrobial resistance in Enterobacterales, Acinetobacter baumannii, Pseudomonas aeruginosa, Staphylococcus aureus and Enterococcus faecium healthcare-associated bloodstream infections in Brazil (ASCENSION): a prospective, multicentre, observational study.

Lancet regional health. Americas·2025

Seven versus 14 days of antimicrobial therapy for severe multidrug-resistant Gram-negative bacterial infections in intensive care unit patients (OPTIMISE): a randomised, open-label, non-inferiority clinical trial.

Critical care (London, England)·2024

Estimating the impact of a healthcare facility-onset antibiotic-treated Clostridioides difficile infection surveillance definition on the number of cases reportable by US veterans affairs medical centers.

Infection control and hospital epidemiology·2026

A quality improvement initiative to optimize diagnostic and antimicrobial stewardship of ventilator-associated tracheitis in the pediatric intensive care unit.

Infection control and hospital epidemiology·2026

Growing carbapenem resistance in South Korea with long-term care facilities as reservoirs.

Infection control and hospital epidemiology·2026

Distinct individual and community-level drivers of extended-spectrum beta-lactamase-producing Enterobacterales urinary tract infections.

Infection control and hospital epidemiology·2026

The efficacy of needleless connector designs (split septum vs mechanical valve) on preventing central line-associated bloodstream infection (CLABSI) in very preterm or very low-birth-weight neonates: a randomized clinical trial.

Infection control and hospital epidemiology·2026

Pathogen genomic surveillance in health care: emerging ethical dilemmas in outbreak detection and patient notification.

Infection control and hospital epidemiology·2026

Hybrid chemical-biogenic synthesis of silver nanoparticles with antibacterial efficacy using Salicornia and Sarcocornia hydroethanolic extracts.

Preparative biochemistry & biotechnology·2026

From nanoscale to clinic: The growing impact of nanotechnology in translational drug delivery.

ADMET & DMPK·2026

Oral co-delivery of quercetin and anthocyanins via dual-ligand nanoparticles alleviate obesity and associated metabolic disorders.

Food research international (Ottawa, Ont.)·2026

Preparation and physicochemical properties of mitochondria-targeted starch nanoparticles.

Food research international (Ottawa, Ont.)·2026

Nanostructured lipid carrier-based gels for nutraceutical delivery: A colloidal perspective beyond traditional emulsion gel systems.

Advances in colloid and interface science·2026

Nano-liposomal encapsulation of isorhamnetin to enhance bioavailability and anticancer efficacy.

Journal of microencapsulation·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us